Healio5h
FDA approves therapies for colorectal cancer, mantle cell lymphoma
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for ...
This disease is known as the ‘silent killer.’ A doctor explains why
People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why you should address them before symptoms begin.
US FDA Approves Omvoh For Severe Crohn’s Disease Relief: All You Need To Know
The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...
MedPage Today6h
Children With IBD Showed Impaired Growth Before Diagnosis
Children who were diagnosed with inflammatory bowel disease (IBD) showed a decline in height, weight, and body mass index ...
Clinical trial advances research in treatment of biliary tract cancers
The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal ...
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...
FDA approves Omvoh for moderately to severely active Crohn's disease
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
Pharmabiz16h
Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults
Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults: Indianapolis Friday, January 17, 2025, 12:00 Hrs [IST] Eli Lilly and Company announced that the US Food ...
WISH-TV on MSN21h
FDA approves Lilly's Omvoh for Crohn's disease
Indianapolis-based Lilly announced Thursday that the U.S. Food and Drug Administration has approved Omvoh for the treatment ...
healthday23h
FDA Approves Omvoh for Moderately to Severely Active Crohn Disease
The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to sever ...